Developing New Drugs for the COVID-19 Emergency: Anatomy of the U.S. Response. [PDF]
Moore TJ, Socal MP, Anderson G.
europepmc +1 more source
Multi spectroscopic investigations with molecular docking and molecular dynamics simulation of the binding mechanism of molnupiravir to bovine serum albumin. [PDF]
Mansour FR +4 more
europepmc +1 more source
Carboxylesterase Factors Influencing the Therapeutic Activity of Common Antiviral Medications Used for SARS-CoV-2 Infection. [PDF]
Shen Y, Eades W, Dinh L, Yan B.
europepmc +1 more source
3,3'-Diindolylmethane Improves the Viral Pneumonia Outcomes After Influenza and SARS-CoV-2 Infection in Animal Models. [PDF]
Kiselev V +11 more
europepmc +1 more source
Development and validation of a RP-HPLC method for simultaneous determination of five COVID-19 antiviral drugs in pharmaceutical formulations. [PDF]
Nassar MW, Serag A, Hasan MA, Kamel M.
europepmc +1 more source
Quality and readability of drug fact sheets for FDA-approved and emergency use authorised drug products for COVID-19 treatment: an observational study. [PDF]
Pranic SM +7 more
europepmc +1 more source
Cardiovascular Safety of COVID-19 Treatments: A Disproportionality Analysis of Adverse Event Reports from the WHO VigiBase. [PDF]
Cheng HK +4 more
europepmc +1 more source

